ClinicalTrials.govpublic full text
Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer
neoplasms, advanced solid malignancy, activity monitor, biosensor, fitbit, patient reported outcomes (pro), stage 3/4 cancer, performance status, eastern cooperative oncology group performance status (ecog-ps), observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 878771
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.